News

Ginkgo Bioworks Collaborates on Advanced Phenotyping Platform

Ginkgo Bioworks Collaborates on Advanced Phenotyping Platform

Ginkgo Bioworks Announces Innovative Partnership

Ginkgo Bioworks has recently secured a significant contract to develop a state-of-the-art High-Throughput Automated Phenotyping Platform (HTP-APP), partnering with the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Laboratory. With a potential value of up to $47 million, this four-year initiative positions Ginkgo as a pivotal player in supporting the U.S. Department of Energy's Microbial Molecular Phenotyping Capability (M2PC).

Driving Innovation in Microbial Research

The purpose of the HTP-APP is to facilitate the generation of high-quality microbial and microbiome data. As the bioeconomy continues to evolve, this platform aims to bolster the U.S. position in biotechnology innovation, ensuring that the country remains competitive and secure. The competitive nature of this procurement underscores the importance of advanced scientific research in addressing economic and societal challenges.

Modular Automation Enhancements

Utilizing Ginkgo's Catalyst scheduling software alongside Reconfigurable Automation Carts (RACs), the platform will automate various workflows, from cultivation to analytics. This means researchers can focus on innovation rather than manual processes. The modular framework allows for easy adjustments as scientific needs shift, facilitating continuous improvement and integration of new methodologies.

Benefits of the HTP-APP

The designed platform not only enhances operational efficiency but also optimizes reliability. By ensuring a robust user-facility environment, the HTP-APP stands to increase the throughput and reproducibility of phenotyping initiatives across a diverse array of microbial studies. It captures critical data while adhering to biosafety regulations.

Leadership Insights on the New Project

Industry leaders at Ginkgo Bioworks have expressed enthusiasm about this collaboration. Will Serber, General Manager of Ginkgo Automation, highlighted that integrating flexible automation with comprehensive software support will enable researchers to generate extensive datasets necessary for modern AI methodologies. Jason Kelly, the CEO, has also underscored how this initiative aligns with national goals for scientific advancement and the competitiveness of the American bioeconomy in global markets.

Future-Ready Capabilities at PNNL

The anticipated outcomes of the M2PC program include a better understanding of complex biological systems, increased data quality, and greater efficiency in experimental workflows. Applied properly, this platform will not only support current research but also pave the way for future scientific endeavors, making it a foundational asset for ongoing innovation.

Core Features and Highlights

The modular architecture of the HTP-APP promises scalability and expandability, allowing for thoughtful adjustments as emerging scientific questions arise. Essential features include end-to-end coverage of various workflows, including media preparation, cultivation, sample handling, and analytics. This comprehensive approach ensures that researchers can generate high-quality multimodal data efficiently and effectively.

About Ginkgo Bioworks

Ginkgo Bioworks is at the forefront of biotechnology, making biology easier to engineer for diverse applications. From R&D services in protein engineering to agriculture and biosecurity, Ginkgo aims to empower partners in various sectors to accelerate their innovation processes. Their automation solutions allow scientists to focus on critical analysis rather than routine tasks, thereby enhancing productivity and research outcomes.

Frequently Asked Questions

What is Ginkgo Bioworks' latest project about?

Ginkgo Bioworks is developing a modular High-Throughput Automated Phenotyping Platform in partnership with PNNL, aimed at enhancing microbial research.

What are the main objectives of the HTP-APP?

The platform will facilitate the generation of comprehensive microbial data to support the U.S. competitiveness in biotechnology and innovation.

How will the new platform benefit researchers?

By automating workflows and providing flexible, scalable solutions, researchers will spend less time on manual tasks and more on innovation.

What technologies will be utilized in this project?

The project will employ Ginkgo's Catalyst scheduling software and Reconfigurable Automation Carts to streamline various research processes.

How does Ginkgo Bioworks contribute to the bioeconomy?

Ginkgo Bioworks develops solutions for protein engineering and agriculture that help drive advancements in biotechnology, supporting the bioeconomy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 7

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 3

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 28

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 5

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 169

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
Al Hurra Cuts Jobs and Merges Iraq Channel Amid Budget Cuts

Updated Category News Views 136

Al Hurra Faces Major Workforce Reductions The parent organization of the Arabic language broadcaster Al Hurra has announced significant layoffs, resulting in the elimination of 160 positions. This decision comes in the wake of a 20% budget cut mandated by the U.S. Congress, as revealed by the company’s CEO in a message to staff. Understanding the Budget Cuts Dr. Jeffrey...

Continue Reading
Strategies for Success in Hinge Research Institute's 2025 Study

Updated Category News Views 627

Innovative Strategies Highlighted in Hinge Research's 2025 Study Hinge Research Institute stands at the forefront of research on professional services growth. With its recent 10th Annual High Growth Study, the institute has delivered crucial insights into how successful firms thrive in today’s rapidly evolving market. The study not only illustrates the growth potential...

Continue Reading
Psyence Biomed Celebrates Milestones in Psilocybin Development

Updated Category News Views 125

Recent Developments in Psyence Biomed's Journey In a significant update shared by Psyence Biomedical Ltd. (Nasdaq: PBM), the company has showcased its achievements, reflecting a positive trajectory in the realm of psychedelic-based therapeutics. Highlights from the update included the impressive valuation of their stake in PsyLabs, strong clinical trial progress, and a...

Continue Reading
Rugby Resources Limited Expands Private Placement Offerings

Updated Category News Views 146

Rugby Resources Limited Expands Private Placement Opportunities Rugby Resources Ltd. (TSX-V: RUG) has announced an important development regarding its private placement offering. Responding to high subscriber demand, the company's board has authorized an increase in the number of available units, raising the offering from 60 million units to an impressive 81.84 million...

Continue Reading